Taking the STING out of Oncology
For many tumor indications optimal treatment selection often depends on the presence of specific tumor biomarkers such as PDL1.
EGFR: Master Regulator of the Oncology Universe
Epidermal growth factor receptor (EGFR), also referred to as ERBB1 or HER1 is part of a broader ERBB family of receptor tyrosine kinases and plays a crucial role in the regulation of cell growth, s
AACR 2024: Spatial Biology, part-2
Spatial biology is an ever-evolving discipline focusing on improving our understanding of biological processes within the context of spatial organization, such as how cells are arranged within tiss
AACR 2024: Drug Targets, part-1
Margaret Foti, PhD, MD, chief executive officer of the American Association for Cancer Research (AACR), kicked off this year’s opening ceremony celebrating an outstanding year for the organization.
Randomized Controlled Trials (RCTs) and Real-world Outcomes in Hematological Malignancies: Minding the Gap
SITC Overview 2023
Following from last year’s record year of attendance held in Boston, this year’s 38th annual Society for Immunotherapy of Cancer (SITC) meeting held in sunny San Diego proved just as popular attrac
NeoGenomics highlighting advances in drug development strategies at recent clinical meetings
NeoGenomics is pleased to have attended meetings this year where we've had the opportunity to highlight advances in drug development strategies.
Women's Health and Fitness Day
September 27 is National Women's Health And Fitness Day. This annual observance strives to spread education about health and wellness, encourage women to prioritize their health, and more.